6/9/2025Kelun-Biotech Secures US$250M in Upsized HK Share Placement

6/9/2025China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs

6/7/2025QureBio Secures ~CNY 100M in Series C1 Financing to Advance BsAb Thera...

6/6/2025Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...

6/5/2025Cullinan Secures Global Rights to Genrix's Velinotamig

6/3/2025BioAge Partners with JiKang Thera for APJ Agonist After Obesity Drug S...

6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

6/3/2025LongBio Secures Over CNY 200M in Series C Financing

6/3/2025Neowise Licenses TCR Candidate to BeiGene for Off-the-Shelf Cell Thera...

6/3/2025Hanx Biopharma Files for Hong Kong IPO to Advance Innovative Cancer Th...

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Regeneron Licenses Hansoh's Dual GLP-1/GIP Receptor Agonist to Bolster...

6/2/2025VelaVigo Expands Global Footprint with Strategic U.S. Biotech Collabor...

6/2/2025BeiGene Redomiciles to Switzerland and Transitions to BeOne Medicines

5/31/2025CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies

5/31/2025Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...

5/29/2025AusperBio Secures $50M in Series B+ Financing

5/29/2025Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million

5/28/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/28/2025Novartis Broadens Alliance with Shanghai Pharma to Include Eye Drugs i...

5/27/2025Pharma Distribution Market Steady with 5.6% Growth in the 14th FYP

5/27/2025Salubris Invests CNY 550M in Next-Gen Hypertension siRNA Therapy with ...

5/27/2025PegBio Debuts on HKEx, Raising HK$300M to Advance GLP-1 Therapies

5/27/2025Sinotau Files for HK IPO to Advance Radiopharma Innovations

5/27/2025XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...

5/23/2025Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...

5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo

5/22/2025Hengrui Pharma Raises $1.27B in Hong Kong Listing

5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare

5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports

Page:4/24 Total number of articles:700: [First][<<] [2] [3] [4] [5] [6] [>>] [End]